Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marion Malphettes

Showing results (1-10 of 90) with videos related to

Pageof 9
Sort By:
La Revue Du Praticien|December 24, 2003
[Thalidomide and others: new treatment for myeloma]Marion Malphettes, Jean-Paul Fermand
Intensive Care Medicine|April 2, 2020
Extensive cutaneous necrosis associated with cryofibrinogenemiaAdrien Mirouse, Marion Malphettes, Maxime Battistella, et al.
Presse Medicale (Paris, France : 1983)|May 20, 2006
[Adult-onset primary hypogammaglobulinemia]Claire Fieschi, Marion Malphettes, Lionel Galicier, et al.
British Journal of Haematology|April 13, 2026
Deciphering the full spectrum of Castleman diseases based on a cohort of 700 patients in a western countryEric Oksenhendler, Marion Malphettes, Véronique Meignin, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 7, 2018
Long-term follow-up of an activated PI3K-δ syndrome 2 in patient presenting with an agammaglobulinemia phenotypeYann Nguyen, Jérémie Rosain, Claire Aguilar, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 13, 2019
Romidepsin is an effective and well-tolerated therapy in CD3<sup>-</sup>CD4<sup>+</sup> lymphocyte-variant hypereosinophilic syndrome: A case reportGildas Baulier, Bouchra Asli, Lionel Galicier, et al.
Gut Microbes|November 20, 2018
Immune/microbial interface perturbation in human IgA deficiencyDelphine Sterlin, Claire Fieschi, Marion Malphettes, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 15, 2016
Exclusion of Patients with a Severe T-Cell Defect Improves the Definition of Common Variable ImmunodeficiencyRémi Bertinchamp, Laurence Gérard, David Boutboul, et al.
Acta Dermato-Venereologica|November 15, 2017
Light Chain Deposition Disease with Bullous Skin Lesions Mimicking Atypical Bullous PemphigoidMarion Malphettes, Pauline Bonnet, Pierre Schneider, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 19, 2022
Campylobacter infection in 4 patients treated with ibrutinibBoris Sorin, Julien Vigneron, Jehane Fadlallah, et al.
Pageof 9

Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
La Revue Du Praticien|December 24, 2003
[Thalidomide and others: new treatment for myeloma]Marion Malphettes, Jean-Paul Fermand
Intensive Care Medicine|April 2, 2020
Extensive cutaneous necrosis associated with cryofibrinogenemiaAdrien Mirouse, Marion Malphettes, Maxime Battistella, et al.
Presse Medicale (Paris, France : 1983)|May 20, 2006
[Adult-onset primary hypogammaglobulinemia]Claire Fieschi, Marion Malphettes, Lionel Galicier, et al.
British Journal of Haematology|April 13, 2026
Deciphering the full spectrum of Castleman diseases based on a cohort of 700 patients in a western countryEric Oksenhendler, Marion Malphettes, Véronique Meignin, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 7, 2018
Long-term follow-up of an activated PI3K-δ syndrome 2 in patient presenting with an agammaglobulinemia phenotypeYann Nguyen, Jérémie Rosain, Claire Aguilar, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 13, 2019
Romidepsin is an effective and well-tolerated therapy in CD3<sup>-</sup>CD4<sup>+</sup> lymphocyte-variant hypereosinophilic syndrome: A case reportGildas Baulier, Bouchra Asli, Lionel Galicier, et al.
Gut Microbes|November 20, 2018
Immune/microbial interface perturbation in human IgA deficiencyDelphine Sterlin, Claire Fieschi, Marion Malphettes, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 15, 2016
Exclusion of Patients with a Severe T-Cell Defect Improves the Definition of Common Variable ImmunodeficiencyRémi Bertinchamp, Laurence Gérard, David Boutboul, et al.
Acta Dermato-Venereologica|November 15, 2017
Light Chain Deposition Disease with Bullous Skin Lesions Mimicking Atypical Bullous PemphigoidMarion Malphettes, Pauline Bonnet, Pierre Schneider, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 19, 2022
Campylobacter infection in 4 patients treated with ibrutinibBoris Sorin, Julien Vigneron, Jehane Fadlallah, et al.
Pageof 9